COLESTYRAMINE AND RELATED DRUGS AND RALOXIFENE
The manufacturers report that the concurrent use of colestyramine reduced the absorption of raloxifene by about 60%, due to an interruption in enterohepatic cycling.
Separating administration is unlikely to be effective as the interaction is via enterohepatic circulation. It is recommended that these two drugs should not be Colestyramine and related drugs
used concurrently. Other drugs, such as colestipol, are expected to interact similarly.
Separating administration is unlikely to be effective as the interaction is via enterohepatic circulation. It is recommended that these two drugs should not be Colestyramine and related drugs
used concurrently. Other drugs, such as colestipol, are expected to interact similarly.